News &amp; Updates

Further lowering blood pressure helps cut the risk of adverse perinatal events for pregnant women with pregestational diabetes mellitus (DM) and mild chronic hypertension, according to the secondary analysis of the Chronic Hypertension and Adverse Pregnancy (CHAP) study presented at SMFM 2023.

Tighter BP control improves pregnancy outcomes in women with DM, chronic hypertension

23 Feb 2023

Sexual boredom, desire patterns vary among adults in long-term relationships

Distinct patterns of sexual boredom and sexual desire exist among individuals in long-term monogamous relationships, reports a study. These patterns are also associated with sexual satisfaction in both men and women and with relationship satisfaction among women only.

Sexual boredom, desire patterns vary among adults in long-term relationships

SBRT plus sorafenib improves survival in HCC

Treatment with stereotactic body radiation therapy (SBRT) followed by sorafenib results in better overall (OS) and progression-free survival (PFS), with no increase in adverse events (AEs), compared with sorafenib monotherapy in patients with hepatocellular carcinoma (HCC), as shown in a phase III study presented at the 2023 ASCO GI Cancers Symposium.

SBRT plus sorafenib improves survival in HCC

23 Feb 2023

FMT prevents recurrent C. difficile infection in IBD patients

Patients with inflammatory bowel disease (IBD) who undergo foecal microbiota transplantation (FMT) are less likely to develop recurrent Clostridioides difficile infection (CDI), a study has shown.

FMT prevents recurrent C. difficile infection in IBD patients

23 Feb 2023

Increased ketorolac doses reduce opioid use following caesarean delivery

In women undergoing caesarean section (C-section), six scheduled doses of ketorolac reduced postoperative opioid use as opposed to having only two doses.

Increased ketorolac doses reduce opioid use following caesarean delivery

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

Treatment with either labetalol or nifedipine is similarly effective in reducing adverse maternal outcomes among women with mild chronic hypertension (CHTN) in pregnancy, according to a study presented at SMFM 2023.

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

Celery seed-derived drug beneficial in ischaemic stroke patients

22 Feb 2023 by

Butylphthalide, a novel medication that contains a compound found in celery, appears to help with functional recovery in patients with ischaemic stroke, as shown in a study presented at ISC 2023.

Celery seed-derived drug beneficial in ischaemic stroke patients

22 Feb 2023

Cannabis use among expectant mums compromises pregnancy

22 Feb 2023 by

Pregnant women may do well to avoid cannabis, with cannabis use in early pregnancy leading to adverse pregnancy outcomes, as reported in a study presented at Society for Maternal-Fetal Medicine (SMFM) 43rd Annual Pregnancy Meeting.

Cannabis use among expectant mums compromises pregnancy

Antithrombotic agents avert death in acute upper GI bleeding

Use of antithrombotic agents (ATs) provides a protective benefit against death in patients with acute upper gastrointestinal bleeding (AUGIB), suggests a study, noting that low-dose aspirin is responsible for such protective effect.

Antithrombotic agents avert death in acute upper GI bleeding

Which ART delivers better HIV viral suppression in pregnant women?

22 Feb 2023 by

Pregnant women living with HIV are more likely to achieve viral suppression when treated with dual-nucleoside reverse transcriptase inhibitors (NRTI) in combination with integrase (INSTI) inhibitors compared to protease (PI) inhibitors at delivery, suggests a recent study presented at the 43rd Annual Pregnancy Meeting of the Society for Maternal Fetal Medicine (SMFM 2023).

Which ART delivers better HIV viral suppression in pregnant women?